7. This blood-based test diagnoses and stages breast cancer
Biotech company Oxford BioDynamics recently created a blood-based test that could successfully diagnose and stage breast cancer.
The test, known as EpiSwitch, was successfully tested on patients who had all four stages of breast cancer. EpiSwitch has high specificity and robustness throughout all of the samples.
EpiSwitch works by monitoring a class of epigenetic biomarkers in the blood known as chromosome conformation signatures (CCSs).